Filing Analysis
InfuSystem Holdings, Inc. reported its financial results for the first quarter of 2026 on May 7, 2026. The announcement was made via a press release furnished under Item 2.02 of the Form 8-K.
Key Facts
- The Company issued a press release reporting Q1 2026 financial results on May 7, 2026.
- The press release is furnished as Exhibit 99.1 to the filing.
- The filing was signed by Barry Steele, the Chief Financial Officer.
InfuSystem Holdings, Inc. announced it will release its first quarter 2026 financial results on May 7, 2026, before the market opens. The company will also host a conference call for investors at 9:00 a.m. Eastern Time on the same day.
Key Facts
- Earnings release date set for Thursday, May 7, 2026.
- Conference call scheduled for May 7, 2026, at 9:00 a.m. ET.
- The filing covers the financial results for the first quarter of 2026.
- The announcement was made via a press release furnished as Exhibit 99.1.
InfuSystem Holdings, Inc. has dismissed Deloitte & Touche LLP and appointed Grant Thornton LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026. The change followed a competitive selection process conducted by the Audit Committee.
Key Facts
- Deloitte & Touche LLP was dismissed on March 13, 2026.
- Grant Thornton LLP was appointed as the new auditor for the 2026 fiscal year on the same date.
- Deloitte's audit reports for the fiscal years ended December 31, 2025, and 2024, contained no adverse opinions or qualifications.
- There were no disagreements with Deloitte on any matter of accounting principles, practices, or financial statement disclosure during the two most recent fiscal years.
- The company did not consult Grant Thornton on any accounting or auditing matters prior to their appointment.
InfuSystem Holdings, Inc. announced that its President and CEO, Carrie Lachance, and CFO, Barry Steele, will participate in the 38th Annual ROTH Conference on March 23, 2026.
Key Facts
- The company will participate in the 38th Annual ROTH Conference on March 23, 2026.
- Key executives attending include CEO Carrie Lachance and CFO Barry Steele.
- The announcement was made via a press release dated March 16, 2026, furnished under Item 7.01.
InfuSystem Holdings, Inc. furnished an updated investor presentation dated February 27, 2026, under Regulation FD.
Key Facts
- The filing was made on February 27, 2026, under Item 7.01 (Regulation FD Disclosure).
- The primary content is an Investor Presentation attached as Exhibit 99.1.
- The information is furnished and not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.
- The report was signed by Barry Steele, the Chief Financial Officer.
InfuSystem Holdings, Inc. reported its financial results for the fourth quarter and full fiscal year 2025. The results were disclosed via a press release on February 24, 2026.
Key Facts
- The filing reports financial results for the fourth quarter and fiscal year ended 2025.
- The report was filed under Item 2.02 (Results of Operations and Financial Condition).
- The press release is included as Exhibit 99.1.
- The report was signed by CFO Barry Steele on February 24, 2026.